Test Price
2,800 AED✅ Home Collection Available
SLC45A2 Gene Sequencing for Oculocutaneous Albinism Type 4 (OCA4) – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل تسلسل جين SLC45A2 للكشف عن المهق العيني الجلدي من النوع 4 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / الملخص التنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview / نظرة عامة على الفحص
The SLC45A2 gene sequencing test utilizes Next-Generation Sequencing (NGS) to detect clinically significant variants associated with Oculocutaneous Albinism Type 4 (OCA4), a genetic disorder characterized by reduced melanin biosynthesis, leading to vision abnormalities, skin/hair hypopigmentation, and increased skin cancer risk. يهدف التحليل إلى تقديم تشخيص جزيئي دقيق للمرضى والأسر مع توجيه الإستشارة الوراثية.
| Feature | Our Test (AMOL, DHA-licensed) | Closest Alternative |
|---|---|---|
| Precision | NGS full gene sequencing with CNV analysis, 99.9% diagnostic sensitivity | Targeted variant panels missing rare SLC45A2 mutations |
| Methodology | ISO 9001:2015 NGS (Illumina platform) | Sanger sequencing (limited throughput) |
| Turnaround Time | 3–4 Weeks (steady, uncompromised quality) | 6–8 Weeks or longer |
Physician Insight & Safety Protocol
“As a DHA-licensed clinician, I emphasize that genetic testing for OCA4 is a powerful tool for confirming the diagnosis, guiding ophthalmologic surveillance, and providing accurate genetic counseling for families. However, a negative result does not rule out albinism entirely; clinical correlation with comprehensive eye and skin exams remains essential.” – Dr. PRABHAKAR REDDY, DHA: 61713011
Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not indicated for asymptomatic minors without a family history of OCA4 or a confirmed genetic diagnosis in an affected parent (per UAE CDS Law 2026).
- Exclusion: Inadequately preserved blood or DNA samples (hemolysis, freeze-thaw cycles) will be rejected.
- ER Red Flag: Sudden vision loss, intense eye pain, or acute onset of photophobia – seek emergency ophthalmic care immediately.
- ER Red Flag: Rapidly changing skin lesions, bleeding moles, or signs of skin cancer – consult a dermatologist or oncologist urgently.
- Pregnancy: Prenatal diagnosis requires formal genetic counseling and informed consent; contact our clinical team for guidance.
Patient FAQ & Clinical Guidance
1. What is the purpose of the SLC45A2 gene test and who should consider it?
This NGS test confirms oculocutaneous albinism type 4 diagnosis, enabling tailored vision care, skin cancer prevention, and precise familial risk assessment. It is recommended for individuals with hypopigmentation and visual deficits, as well as relatives of known OCA4 patients seeking carrier status.
2. كيف يتم جمع العينة ومدة ظهور النتائج؟
نوفر خدمة سحب الدم المنزلي بواسطة فريق تمريض متنقل تحت سلسلة تبريد معيارية ISO طوال اليوم حتى 11 مساءً، وتظهر النتائج الكاملة خلال 3 إلى 4 أسابيع من الاستلام.
3. Is the covered by UAE health insurance?
Yes, many UAE insurers cover genetic testing for albinism when medically indicated; we provide direct billing verification via WhatsApp (+971 54 548 8731). Always confirm eligibility with your provider before sample collection.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians